Evridiki Michali

Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide

Meletios Α. Dimopoulos, Athanasios K. Anagnostopoulos, Marie‐Christine Kyrtsonis et al. · Journal of Clinical Oncology · 2007 · 277 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +15

Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance

V. Eleutherakis-Papaiakovou, Aristotelis Bamias, Dimitra Gika et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 228 citations

Medicine, Hematology, Nephrology +15

Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)

Efstathios Kastritis, Konstantinos Zervas, Argiris Symeonidis et al. · Leukemia · 2009 · 187 citations

Medicine, Hematology, Oncology +17

Proliferation and bone marrow engraftment of AML blasts is dependent on β‐catenin signalling

Elena K. Siapati, M. Papadaki, Zoi Kozaou et al. · British Journal of Haematology · 2010 · 43 citations

Life Sciences, Cell Biology, Hematology +17

“Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group

Eirini Katodritou, Chrysanthi Vadikolia, Chrysavgi Lalagianni et al. · Annals of Hematology · 2013 · 39 citations

Medicine, Pharmacology, Pharmacotherapy +16